SBRI Healthcare

Presymptom Health is a medical technology company dedicated to advancing healthcare through the development of pre-symptomatic diagnostic tests and clinical decision support algorithms. The company focuses on creating innovative blood tests designed to detect illnesses at an early stage, particularly aiming to predict the onset of sepsis up to three days before symptoms manifest. By enabling earlier intervention, Presymptom Health seeks to improve critical care outcomes and enhance patient management, ultimately contributing to better survival rates and healthcare efficiency.

Inavya Ventures Ltd is a healthcare technology company based in London, United Kingdom, founded in 2015. The company specializes in developing an artificial intelligence-based personalized robot designed to enhance healthcare delivery. This innovative mobile cyber assistant utilizes machine learning technology to facilitate the management and ownership of personal data by users. Additionally, Inavya Ventures has created a regulated medical-grade device that integrates with various medical and environmental devices, aiming to improve patient care and streamline healthcare processes.

Huma is a global health technology company that provides a modular platform to support digital hospitals at home across disease areas. The platform combines predictive algorithms, digital biomarkers, and real-world data to enable proactive and predictive care and research. It integrates data from hospital databases, patient wearables, and mobile devices to deliver real-time information to healthcare providers, supporting connected care. Through collaborations with leading healthcare institutes, Huma uses data and clinical expertise to measure outcomes and accelerate research and therapies, helping clinicians deliver better patient care.

PatientMpower specializes in remote monitoring solutions for patients with chronic diseases, particularly those with respiratory conditions. The company develops applications that integrate with devices such as spirometers and pulse oximeters, allowing patients to conduct health measurements from home. These devices connect to a smartphone application, which facilitates the transmission of real-time data to healthcare providers. This integration enhances the ability of healthcare workers to deliver high-quality care and monitor patient progress effectively. Additionally, PatientMpower’s solutions contribute to research efforts aimed at improving treatment methodologies, ultimately supporting better health outcomes for patients.

Revolution-ZERO specializes in sustainable medical textile solutions. It offers reusable personal protective equipment (PPE) and other medical textiles, along with comprehensive services including implementation, supply, logistics, and decontamination. The company also provides consulting services for green plans, innovation projects, and business cases, aiming to reduce waste and carbon emissions in the medical industry.

MediSyne develops novel medical devices to support clinicians and expertise in health informatics, clinical systems and surgical technology.

Walk With Path specializes in developing wearable products that enhance mobility and provide therapeutic benefits for patients. The company's primary offering is a smart insole equipped with biofeedback and sensors, specifically designed to assist individuals with diabetes in improving balance and preventing foot ulcers. One of their key innovations, the Path Finder, is a medical device aimed at helping individuals with Parkinson's disease manage 'freezing of gait,' a condition where patients feel momentarily stuck. This product has shown efficacy through published evidence in Neurology. Walk With Path also offers data insights and analytics for both end users and healthcare professionals, making their products applicable for daily use and gait analysis in clinical and non-clinical settings.

Alvie Health is a company that specializes in providing health coaching and expert support aimed at enhancing the well-being of patients, particularly those undergoing treatment for cancer and surgery. It has developed a digitally-enabled behavior change platform that focuses on improving clinical outcomes and quality of life for patients. By utilizing personalization algorithms, the platform creates risk-stratified, clinically proven rehabilitation programs tailored to individual needs. These programs support patients on elective care pathways by tracking health behaviors, logging symptoms, and integrating behavior change principles, ultimately facilitating efficient and high-quality health outcomes.

Lenus Health develops a remote patient monitoring platform that collects patient-generated health data from wearable devices, sensors, and applications and presents it in an intelligent, customizable dashboard for care teams to remotely monitor patient wellbeing, enabling earlier intervention and the prevention of disease exacerbations and hospitalizations. The company also offers a machine-learning disease management component to digitally empower clinical care pathways and further support proactive care.

Aseptika Ltd., founded in 2007 and based in Huntingdon, United Kingdom, is a healthcare company specializing in the development and marketing of self-monitoring devices and services. These products are designed to help consumers and their healthcare providers manage long-term health conditions effectively. Aseptika offers a range of devices including activity trackers, body analyzers, blood pressure monitors, pulse oximeters, peak flow meters, POGO USB hubs, contactless thermometers, and more. Additionally, the company provides health monitoring applications, food diary apps, clinical applications for lung health management, and software for various platforms. These products are utilized for self-monitoring, biomarker tests, staying connected, clinical trials, corporate wellness programs, and healthcare collaborations. Aseptika's devices are distributed through a network of distributors.

Adherium develops digital health technologies to improve medication adherence in chronic diseases worldwide. It offers Hailie, an asthma and COPD medication tracker comprising Bluetooth sensors for inhalers and a smartphone app for patients, caregivers, and healthcare professionals.

UNEEG Medical develops a medical device for long-term Electroencephalography (EEG) monitoring, providing healthcare professionals with objective insights into seizure activity in epilepsy care.

PinPoint Data Science, established in 2016 and headquartered in Leeds, United Kingdom, specializes in developing technology for early cancer detection. The company focuses on creating a test that employs machine learning to integrate data from various cancer biomarkers and patient information, aiming to enhance the accuracy of cancer diagnosis at an early stage.

The endoscope-i adapter and app enables HD display of endoscope imaging directly to a smart phone, vastly improving both patient understanding of their condition and the documentation of clinical findings. It also opens the door to remote specialist opinions and new patient centred, specialist delivered service pathways.

Skin Analytics is a London-based company that uses smartphone imagery and artificial intelligence to create a digital history of a patient’s skin, enabling clinicians to measure changes over time, assess treatment options, and support early detection of skin cancers such as melanoma. Its platform analyzes images of moles and skin lesions to monitor progression, standardize patient management, and potentially reduce diagnostic wait times, with applications spanning consumer skin health and clinical settings, including use within the NHS.

52 North Health develops an AI-powered medical device for determining neutropenic sepsis risk in chemotherapy patients. Its portable finger-prick blood test measures neutrophil count and C-Reactive Protein (CRP) levels at home, enabling early detection and improved management of this fatal side effect.

NeuroResponse is a healthcare company that provides patients with Multiple Sclerosis necessary access to clinicians to obtain medications.

Revolution-ZERO specializes in sustainable medical textile solutions. It offers reusable personal protective equipment (PPE) and other medical textiles, along with comprehensive services including implementation, supply, logistics, and decontamination. The company also provides consulting services for green plans, innovation projects, and business cases, aiming to reduce waste and carbon emissions in the medical industry.

Odstock Medical provides functional electrical stimulation and clinical services. They provide FES treatment that uses electrical current to stimulate nerves and move paralyzed muscles. They continue to help raise the awareness of FES as part of a patient’s neurological rehabilitation.

IbisVision Limited is a company that specializes in developing visual field test software aimed at the early detection of glaucoma, a leading cause of blindness. Its flagship product, Ring of Sight, utilizes patented technology to offer a unique eye testing experience through a cloud-based application that can be accessed remotely from various locations. The software consolidates multiple eye tests into one device, allowing healthcare professionals to conduct both in-practice and no-contact testing. This innovative approach not only enhances patient care but also supports optometrists in maximizing operational efficiency. Founded in 2013 and located in Livingston, United Kingdom, IbisVision is committed to improving eye care by providing a reliable and secure platform for diagnosing and monitoring glaucoma. The application ensures data privacy through secure encrypted servers, underscoring the company's dedication to maintaining high standards of patient confidentiality and security.

Evolv Rehabilitation Technologies S.L. is a company focused on developing software and hardware medical devices that specialize in rehabilitation technologies, particularly for neurorehabilitation, orthopedic rehabilitation, and geriatric care. The company has created VirtualRehab, a cloud-based tele-rehabilitation platform that incorporates virtual reality, motion capture systems, and gamification to enhance traditional therapy methods. Established in 2017, Evolv is headquartered in Basauri, Spain.

Newcastle Hospitals NHS Foundation Trust is one of the busiest, largest and most successful teaching NHS foundation trusts in the country. They support people with a range of rare and complex medical, surgical and neurological conditions, cancers and genetic orders. These include a range of flagship services which deliver cutting-edge care and are a catalyst for innovation to support pioneering clinical practice in the NHS.

52 North Health develops an AI-powered medical device for determining neutropenic sepsis risk in chemotherapy patients. Its portable finger-prick blood test measures neutrophil count and C-Reactive Protein (CRP) levels at home, enabling early detection and improved management of this fatal side effect.

MedtechtoMarket is a rapid, low cost test for early detection of Sepsis.

Invitron is a biotechnology company with specialist expertise in the development and manufacture of high sensitivity in-vitro diagnostics.

Psyros Diagnostics is a manufacturer of point-of-care clinical diagnostic equipment located in Sandwich, United Kingdom. The company specializes in developing innovative diagnostic solutions that utilize proprietary technology based on digital single-molecule counting. This advanced approach enables the detection of biomolecules at femtomolar levels, facilitating rapid and accurate testing directly at the patient's bedside. By ensuring that patients receive the appropriate tests at the right time, Psyros Diagnostics aims to enhance diagnostic accuracy and improve overall patient outcomes.

Invitron is a biotechnology company with specialist expertise in the development and manufacture of high sensitivity in-vitro diagnostics.

Oxford Heartbeat develops medical device software to improve surgical planning and execution. The platform allows surgeons to visualize what is happening inside blood vessels and surrounding tissues and bones, offering unprecedented visibility for minimally invasive, keyhole procedures. Through predictive computations, big data and AI, it enables rehearsals of procedures and helps choose the best surgical scenario for each patient in advance. Better preparation aims to reduce complication rates and related costs while delivering improved patient care.

Ceryx Medical Limited is a biotechnology company based in Bath, United Kingdom, founded in 2016. The company specializes in developing and manufacturing innovative bio-electronic devices that utilize unique, patent-protected chip technology. These devices are designed to mimic Central Pattern Generators (CPGs), which are nerve centers in the body responsible for regulating various autonomic and rhythmical processes, including peristalsis, heart rate, and walking. Ceryx Medical aims to restore normal physiological functions that may be compromised due to disease or injury by employing artificial CPGs in their therapeutic devices.

Zilico develops medical diagnostic devices using electrical impedance spectroscopy technology. Its primary product, ZedScan, enhances cervical cancer diagnosis by providing real-time, objective assessments alongside colposcopy.

Lightpoint Medical, Ltd. is a medical device company based in Rickmansworth, United Kingdom, founded in 2012. The company specializes in developing innovative imaging technologies for cancer surgery, specifically through its Cerenkov Luminescence Imaging (CLI) technology. This breakthrough intraoperative imaging method enables real-time cancer detection during surgical procedures, which can significantly reduce the chances of cancer recurrence and the need for subsequent operations. Lightpoint Medical's tools are designed to enhance the effectiveness of robotic cancer surgeries, providing healthcare professionals with critical insights that improve surgical decision-making and patient outcomes while also aiming to lower healthcare costs.

Mogrify develops proprietary platform technologies that enable direct cellular reprogramming. These platforms use big-data approaches to predict transcription factors and growth factors required for producing any target human cell type from any source human cell type. Mogrify applies these platforms to generate functional cell types for in vivo reprogramming therapies, focusing on ophthalmology, otology, metabolic diseases, and other degenerative conditions.

getUBetter is a digital health company specialising in musculoskeletal conditions. It offers a platform that empowers patients to manage their recovery and prevention of common injuries and conditions, such as back, leg, neck, shoulder, knee, and ankle pain. The platform provides evidence-based support, aiming to avoid care silos and reduce over-treatment, thereby promoting more efficient use of healthcare resources.

BIOS Health is a pioneering company focused on developing neural digital therapies by harnessing data-driven insights from the human nervous system. Co-founded by researchers from Cambridge University, the firm aims to revolutionize precision medicine through the identification of neural biomarkers that link nerve activity to various medical conditions. BIOS's innovative approach holds promise for treating chronic diseases such as hypertension, diabetes, rheumatoid arthritis, and neurodegenerative disorders like Parkinson's and Alzheimer's. The company's expertise encompasses a diverse range of fields, including neuroscience, machine learning, software engineering, and biotechnology, allowing it to create advanced solutions for improving the quality of life for individuals suffering from these conditions. Additionally, BIOS is engaged in developing prosthetic connectors that standardize the interface between bionic devices and the body's nervous and soft-tissue systems, enabling enhanced control and feedback for patients with prosthetics.

Chondrogenix Ltd. is a biotechnology company based in Cambridge, United Kingdom, focused on developing innovative treatments for cartilage degeneration. Founded in 2017, Chondrogenix utilizes data-driven technology to create regenerative therapies aimed at cartilage regeneration. The company's proprietary approach involves converting various starting cell types into functional chondrocytes, which can spontaneously form cartilage. This technology offers healthcare professionals a safe, efficient, and scalable source of therapeutic cells for treating osteoarthritis. As a wholly owned subsidiary of Mogrify Ltd., Chondrogenix is dedicated to advancing solutions that address the challenges associated with cartilage degeneration.

MediSieve Ltd. is a London-based medical device company specializing in Magnetic Blood Filtration (MBF) technology aimed at treating blood-borne diseases. Founded in 2014, the company has developed a system that utilizes a magnetic filter to physically remove infected blood cells from a patient's bloodstream. The process involves circulating blood through an external loop where targeted magnetic particles are infused, binding to disease-relevant targets. This filtered blood then passes through a magnetic filter that captures the particles and bound targets, allowing the unaffected blood to return to the patient without the particles entering their body. MediSieve's innovative approach is applicable to various conditions, including malaria, leukaemia, sepsis, and other blood-borne diseases, enhancing the efficacy and safety of existing therapies. The company operates out of the Imperial Incubator in White City, London, where it conducts product development and validation in its dedicated laboratory facilities.

Chromition Limited, established in 2014 and headquartered in Manchester, UK, specializes in developing and supplying advanced nanoparticle solutions for various commercial applications. The company's portfolio includes Luminspheres, multi-colored photoluminescent polymer nanoparticles used in bio-imaging, anti-counterfeit measures, and lighting; Elecspheres, semiconductor polymer nanoparticle aqueous inks applied in displays, electronics, lighting, solar cells, and sensors; and Dielecspheres, high-k dielectric films that allow electronic devices to function at ultra-low voltages and low power. Chromition's technology originated from research at the University of Manchester and has been commercialized for next-generation optoelectronic products.

Cambridge Oncometrix is a company focused on improving prostate cancer detection, a condition affecting 1 in 7 men globally. It specializes in the development of a non-invasive risk stratification test designed to facilitate the early detection of prostate cancer. This innovative laboratory test aims to accurately identify men who would benefit from mpMRI-guided biopsies, enabling them to monitor their prostate health regularly and take necessary precautions. By enhancing the accuracy of prostate cancer screening, Cambridge Oncometrix seeks to save lives through early intervention and increased awareness of this prevalent health issue.

Bioinduction is a company focused on developing innovative neuromodulation devices aimed at treating chronic pain and various neurological disorders. Their flagship product is a skull-mounted deep brain stimulation (DBS) platform, which integrates advanced features such as neural recording and target steering. This design enhances the productivity of surgical teams while prioritizing patient comfort, as the unique placement on the skull offers significant advantages over traditional DBS devices. Bioinduction's approach represents a faster and simpler solution in the field of deep brain stimulation, positioning the company as a notable player in neurological treatment technology.

Lightpoint Medical, Ltd. is a medical device company based in Rickmansworth, United Kingdom, founded in 2012. The company specializes in developing innovative imaging technologies for cancer surgery, specifically through its Cerenkov Luminescence Imaging (CLI) technology. This breakthrough intraoperative imaging method enables real-time cancer detection during surgical procedures, which can significantly reduce the chances of cancer recurrence and the need for subsequent operations. Lightpoint Medical's tools are designed to enhance the effectiveness of robotic cancer surgeries, providing healthcare professionals with critical insights that improve surgical decision-making and patient outcomes while also aiming to lower healthcare costs.

Oxford Heartbeat develops medical device software to improve surgical planning and execution. The platform allows surgeons to visualize what is happening inside blood vessels and surrounding tissues and bones, offering unprecedented visibility for minimally invasive, keyhole procedures. Through predictive computations, big data and AI, it enables rehearsals of procedures and helps choose the best surgical scenario for each patient in advance. Better preparation aims to reduce complication rates and related costs while delivering improved patient care.

Cadscan Limited is a company specializing in the development of 3-dimensional (3D) products for the healthcare, dental, and industrial sectors. Founded in 2011 and based in Chester, United Kingdom, Cadscan integrates imaging, 3D printing, and 3D visualization technologies to create innovative products. Its offerings include 3D printed insoles, solutions for wound management, and robotic inspection systems. The company also develops a range of medical devices, such as custom orthotics, and employs advanced 3D scanning techniques for various applications. Cadscan Limited's focus on combining cutting-edge technology with practical healthcare solutions positions it as a key player in its industry.

Developer of AI-driven respiratory diagnostic technologies. Its novel sensor technology (N-Tidal) rapidly converts lung function data into respiratory biomarkers for near-real-time analysis. TidalSense has created an affordable, automated COPD diagnostic test that interprets results in under five minutes.

Cambridge Oncometrix is a company focused on improving prostate cancer detection, a condition affecting 1 in 7 men globally. It specializes in the development of a non-invasive risk stratification test designed to facilitate the early detection of prostate cancer. This innovative laboratory test aims to accurately identify men who would benefit from mpMRI-guided biopsies, enabling them to monitor their prostate health regularly and take necessary precautions. By enhancing the accuracy of prostate cancer screening, Cambridge Oncometrix seeks to save lives through early intervention and increased awareness of this prevalent health issue.

Cadscan Limited is a company specializing in the development of 3-dimensional (3D) products for the healthcare, dental, and industrial sectors. Founded in 2011 and based in Chester, United Kingdom, Cadscan integrates imaging, 3D printing, and 3D visualization technologies to create innovative products. Its offerings include 3D printed insoles, solutions for wound management, and robotic inspection systems. The company also develops a range of medical devices, such as custom orthotics, and employs advanced 3D scanning techniques for various applications. Cadscan Limited's focus on combining cutting-edge technology with practical healthcare solutions positions it as a key player in its industry.

Bioinduction is a company focused on developing innovative neuromodulation devices aimed at treating chronic pain and various neurological disorders. Their flagship product is a skull-mounted deep brain stimulation (DBS) platform, which integrates advanced features such as neural recording and target steering. This design enhances the productivity of surgical teams while prioritizing patient comfort, as the unique placement on the skull offers significant advantages over traditional DBS devices. Bioinduction's approach represents a faster and simpler solution in the field of deep brain stimulation, positioning the company as a notable player in neurological treatment technology.

Oxford Heartbeat develops medical device software to improve surgical planning and execution. The platform allows surgeons to visualize what is happening inside blood vessels and surrounding tissues and bones, offering unprecedented visibility for minimally invasive, keyhole procedures. Through predictive computations, big data and AI, it enables rehearsals of procedures and helps choose the best surgical scenario for each patient in advance. Better preparation aims to reduce complication rates and related costs while delivering improved patient care.

Vodca Ltd augmented microbiome-Mediated Breath Test for Earlier Oesophago-Gastric Cancer Diagnosis.

Chromition Limited, established in 2014 and headquartered in Manchester, UK, specializes in developing and supplying advanced nanoparticle solutions for various commercial applications. The company's portfolio includes Luminspheres, multi-colored photoluminescent polymer nanoparticles used in bio-imaging, anti-counterfeit measures, and lighting; Elecspheres, semiconductor polymer nanoparticle aqueous inks applied in displays, electronics, lighting, solar cells, and sensors; and Dielecspheres, high-k dielectric films that allow electronic devices to function at ultra-low voltages and low power. Chromition's technology originated from research at the University of Manchester and has been commercialized for next-generation optoelectronic products.

Corporate Health creating highly automated, primary-care delivered video capsule endoscopy diagnostics.

Helicon Health is a medical technology company focused on digital healthcare solutions to improve patient outcomes and lower the cost of chronic disease management. It provides a digital platform that includes electronic health records, an anticoagulant advisory system, patient self-monitoring capabilities, and telemedicine services, enabling healthcare professionals to support early detection, accurate diagnosis, and timely treatment for individuals with multiple long-term conditions.

Skin Analytics is a London-based company that uses smartphone imagery and artificial intelligence to create a digital history of a patient’s skin, enabling clinicians to measure changes over time, assess treatment options, and support early detection of skin cancers such as melanoma. Its platform analyzes images of moles and skin lesions to monitor progression, standardize patient management, and potentially reduce diagnostic wait times, with applications spanning consumer skin health and clinical settings, including use within the NHS.

Corporate Health creating highly automated, primary-care delivered video capsule endoscopy diagnostics.

PMD Solutions develops and markets medical devices for continuous respiratory monitoring. The flagship product RespiraSense is a discrete, motion-tolerant, body-worn sensor that continuously measures respiratory rate to monitor patients from administration to discharge, enabling early detection of deterioration and reducing the risk of respiratory failure. The system is commercially deployed in Europe and the United Kingdom and is FDA-cleared in the United States, targeting hospital and homecare settings.

Highland Biosciences improving efficiency of acute care with a near-patient coagulopathy biosensor.

Developer of AI-driven respiratory diagnostic technologies. Its novel sensor technology (N-Tidal) rapidly converts lung function data into respiratory biomarkers for near-real-time analysis. TidalSense has created an affordable, automated COPD diagnostic test that interprets results in under five minutes.

MedtechtoMarket is a rapid, low cost test for early detection of Sepsis.

Viamed focuses on the development, manufacture and distribution of innovative medical products.

Saccade Diagnostics brings to market for the first time clinically-validated objective tests to help clinicians with diagnostic evaluation and management of psychiatric disorders in patients with mental health complaints. A spin-out from the University of Aberdeen, Saccade has devised a rapid eye-movement test called SaccScan that can help medical professionals diagnose a range of psychiatric disorders, such as schizophrenia, bipolar disorder and major depression within just 30 minutes. It is non-invasive, affordable and easy to administer, allowing non-specialists to operate it with minimal training. The academic founders, Philip Benson and David St Clair, teamed up with Madhu Nair, who took on the role of commercial champion and CEO.

Founded in 2008, Manus Neurodynamica specializes in medical diagnostic technologies for neuromotor impairments. Its primary product is a non-invasive device designed to support early diagnostics and monitoring of Parkinson's disease, with applications in academic research, pharmaceutical studies, and non-medical uses.

Orsus Medical, established in 2015 and headquartered in Chepstow, UK, specializes in the manufacture and distribution of wristband sensors. These sensors are designed to non-invasively monitor blood glucose levels in real-time and continuously, targeting the diabetic population. The company operates as a subsidiary of Afon Technology Limited.

MicroBioSensor is a diagnostics company that develops disposable point-of-care devices to detect early-stage bacterial infections. Its initial focus is on early infection detection for patients on peritoneal dialysis and on guiding antibiotic selection for suspected urinary tract infections. The company also designs point-of-care tests and safety monitors that can be embedded in existing medical devices, such as dialysis equipment and wound dressings, for use by untrained workers in care homes or pharmacies, enabling earlier intervention at low cost and improving patient care.

PolyPhotonix is a bio-photonic company focused on research, development, and manufacture of non-invasive light therapy medical devices. It designs and produces home care products that apply light therapy to treat eye diseases such as macular degeneration and diabetic retinopathy. The company collaborates with designers and key customers to advance products from concept through manufacturing and is based at the National Printable Electronics Centre.

Therapy Box apps are compatible with iDevices including iPod touch, iPad and iPhone and Android Devices. The business also provides iPad Bundles, communication accessories and training for UK and Ireland customers. They seek to apply the latest innovations in app development to meet the needs of those who have communication difficulties due to a range of disabilities arising from cerebral palsy, motor neurone disease, autism, Brain Injuries and other neurological and developmental disorders. It is important to us that their devices are affordable, easy to use and of high quality. Their aim is to supply the best means of communication possible to their customers to enable them to express themselves with their family, friends and colleagues in a whole range of environments. They believe that their commitment to providing the best customer service is what sets us apart. From requesting a quote to supporting you with your equipment, they will be there to support you every step of the way. Having made a huge impact on the AAC industry, they will continue to bring you the most innovative, cutting edge and creative apps available today.

DynamX Medical is a healthcare technology company that has created an innovative precancer screening system designed for rapid tissue biopsy analysis. This system is user-friendly and can be operated at the point of care by nurses, enhancing accessibility and efficiency in medical settings. The company's software aims to streamline disease diagnosis by increasing the speed and reliability of detection, thereby alleviating the workload on healthcare institutions. Through its novel technology, DynamX Medical seeks to improve diagnostic processes, ultimately supporting better patient outcomes and reducing the strain on healthcare resources.

Highland Biosciences improving efficiency of acute care with a near-patient coagulopathy biosensor.

Open Bionics develops advanced bionic limbs for individuals with upper limb differences. It specializes in the Hero Arm, a lightweight, ventilated multi-grip bionic arm featuring adjustable sockets and aesthetic covers. The company offers custom-fitted designs using 3D printing technology, aiming to make cutting-edge bionic solutions more accessible.

Aseptika Ltd., founded in 2007 and based in Huntingdon, United Kingdom, is a healthcare company specializing in the development and marketing of self-monitoring devices and services. These products are designed to help consumers and their healthcare providers manage long-term health conditions effectively. Aseptika offers a range of devices including activity trackers, body analyzers, blood pressure monitors, pulse oximeters, peak flow meters, POGO USB hubs, contactless thermometers, and more. Additionally, the company provides health monitoring applications, food diary apps, clinical applications for lung health management, and software for various platforms. These products are utilized for self-monitoring, biomarker tests, staying connected, clinical trials, corporate wellness programs, and healthcare collaborations. Aseptika's devices are distributed through a network of distributors.

Folium Optics, established in 2013 by Steve Kitson and John Rudin, specializes in developing electronic devices to enhance medication adherence. The company's primary product is a wireless tag attached to medical packaging, connected to a remote cloud service, and a portable reminder unit. This system allows pharmacists, caregivers, and users to effectively manage and monitor medication intake. Folium Optics operates from an industrial unit in Thornbury, Bristol, equipped with an advanced cleanroom for product development and prototyping, and employs a team of scientists, engineers, and management professionals.

Renephra Ltd., established in 2009 and headquartered in Manchester, UK, is a medical device company specializing in controlled fluid removal from the skin. Its core product employs Transdermal Fluid Removal (TFR) technology, combining micro-needles with negative pressure therapy to enable minimally invasive extraction of excess interstitial fluid. Renephra targets fluid overload and chronic oedema/lymphoedema in vascular, oncology, and other disease areas, addressing significant unmet clinical needs in an estimated £1 billion global market.

CareflowConnect creates a real-time clinical communications network which transforms how healthcare teams work together to improve patient safety and outcomes.

MIRA Rehab is a company focused on enhancing physical therapy through innovative technology. It has developed a platform that transforms traditional rehabilitation exercises into engaging video games, making the recovery process more enjoyable for patients recovering from surgery or injury. Utilizing motion-sensing technology, such as Microsoft Kinect, the system tracks user movements from a distance, allowing for objective assessment of performance and compliance without physical contact. This approach not only motivates patients but also tailors exercises to accommodate various pathologies, ensuring that rehabilitation is both effective and personalized.

Sky Medical Technology specializes in bioelectronic medicine, developing wearable devices that enhance blood circulation. Its flagship product, OnPulse™, is a neuromodulation therapy clinically proven to prevent and treat various vascular conditions such as life-threatening blood clots, post-surgical swelling, non-healing wounds, and muscle recovery for athletes.

Blue Maestro is a leading designer and developer of connected products and solutions, from consumer devices through to their work with NHS England on the next generation of medicine adherence sensors. They have a number of innovative products and solutions under development, several that are patent pending. Meet some of Blue Maestro’s management team below.

Docobo Ltd is a UK-based medical device company specializing in eHealth solutions aimed at enhancing community care and improving the quality of life for patients, caregivers, and clinicians. The company has developed a digital health and data management platform that facilitates out-of-hospital care by enabling the collection, analysis, and display of patient monitoring data. This platform manages the secure connection, encryption, and transfer of data between the server and patient interaction devices. It empowers patients to self-manage their health at home while allowing clinical teams to enroll, set up, and oversee their patients through secure web interfaces.

11 Health is a healthcare company founded by Michael Seres, an innovator with personal experience as an ostomy patient. Diagnosed with Crohn’s Disease at the age of 12, Seres underwent numerous medical procedures, including a small bowel transplant, which inspired him to create solutions for others in similar situations. The company has developed a virtual healthcare ecosystem that provides an integrated care experience for ostomy patients. This ecosystem includes a range of products and services aimed at connecting patients with their medical teams, facilitating recovery after transplantation, and reducing hospital readmissions for ileostomy patients. Through its innovative approach, 11 Health seeks to improve the quality of care and support for individuals living with ostomies.

Rapid Rhythm is a medical device company focused on developing innovative cardiac diagnostic tools. Their primary product is a single-lead ECG handset designed for rapid, one-step heart rhythm analysis in primary care and acute settings, aiming to replace traditional 12-lead ECGs. The company's mission is to accelerate the diagnosis of atrial fibrillation, an abnormal heart condition, thereby improving patient outcomes through early detection and intervention.

Acute Technology Ltd Improving medication adherence by remote monitoring of monitored dosage system trays.

Ally Labs aims to demonstrate the technical feasibility and benefits of an in-home early warning system for detecting increased frailty in elderly individuals.

Rinicare Ltd. is a healthcare technology company based in Macclesfield, United Kingdom, specializing in the design and manufacture of innovative monitoring devices. The company offers a range of products, including the PRIME device, which utilizes wireless sensors for vital sign monitoring and data analysis, allowing clinicians to remotely visualize, transmit, and store patient data. Additionally, Rinicare has developed PRIME IoT, which facilitates the transmission of vital sign data to compatible devices through healthcare application software. The company also focuses on patient safety with its SAFE system, a falls detection and prevention solution that employs thermal imaging sensors and intelligent algorithms to monitor patients' positions in bed, alerting clinicians to potential fall risks. Through these technologies, Rinicare aims to enhance patient care by providing real-time insights that support informed decision-making in clinical settings. Established in 2002, Rinicare continues to innovate within the healthcare sector.

PolyPhotonix is a bio-photonic company focused on research, development, and manufacture of non-invasive light therapy medical devices. It designs and produces home care products that apply light therapy to treat eye diseases such as macular degeneration and diabetic retinopathy. The company collaborates with designers and key customers to advance products from concept through manufacturing and is based at the National Printable Electronics Centre.

OBS Medical Ltd., headquartered in Abingdon, United Kingdom, with additional offices in the United States, specializes in designing and developing monitoring products for various healthcare applications. The company's portfolio includes physiological monitoring systems like Visensia Bedside and Visensia Central Station, which help detect early clinical patient deterioration and provide centralized displays for nurses. OBS Medical also offers software and hardware solutions for managing chronic conditions such as asthma, blood pressure, COPD, and diabetes, along with alarm systems for wellness, falls, dementia, and wandering monitoring in nursing homes or individual residences. Their mPRO solution allows real-time tracking of trial progress in clinical research. Additionally, the company provides project management, consultancy, installation, technical support, integration services, repair, training, patient recruitment, education, advice, and monitoring services for clinical trials organizations. OBS Medical is recognized as a global leader in developing predictive algorithms to identify critical instability in patients that traditional methods may miss, aiming to reduce unexpected and avoidable deaths through risk identification and prevention.

Lucid aims to develop a unique 3 in one diagnostic device. The device would help intuitive, fast and economic measure biophysiological markers (pressure, sensation and muscle contractility – via EMG), enabling more precise diagnosis of the functional deficits in faecal incontinence at primary care.

Blue Maestro is a leading designer and developer of connected products and solutions, from consumer devices through to their work with NHS England on the next generation of medicine adherence sensors. They have a number of innovative products and solutions under development, several that are patent pending. Meet some of Blue Maestro’s management team below.

OBS Medical Ltd., headquartered in Abingdon, United Kingdom, with additional offices in the United States, specializes in designing and developing monitoring products for various healthcare applications. The company's portfolio includes physiological monitoring systems like Visensia Bedside and Visensia Central Station, which help detect early clinical patient deterioration and provide centralized displays for nurses. OBS Medical also offers software and hardware solutions for managing chronic conditions such as asthma, blood pressure, COPD, and diabetes, along with alarm systems for wellness, falls, dementia, and wandering monitoring in nursing homes or individual residences. Their mPRO solution allows real-time tracking of trial progress in clinical research. Additionally, the company provides project management, consultancy, installation, technical support, integration services, repair, training, patient recruitment, education, advice, and monitoring services for clinical trials organizations. OBS Medical is recognized as a global leader in developing predictive algorithms to identify critical instability in patients that traditional methods may miss, aiming to reduce unexpected and avoidable deaths through risk identification and prevention.

MIRA Rehab is a company focused on enhancing physical therapy through innovative technology. It has developed a platform that transforms traditional rehabilitation exercises into engaging video games, making the recovery process more enjoyable for patients recovering from surgery or injury. Utilizing motion-sensing technology, such as Microsoft Kinect, the system tracks user movements from a distance, allowing for objective assessment of performance and compliance without physical contact. This approach not only motivates patients but also tailors exercises to accommodate various pathologies, ensuring that rehabilitation is both effective and personalized.

Cadscan Limited is a company specializing in the development of 3-dimensional (3D) products for the healthcare, dental, and industrial sectors. Founded in 2011 and based in Chester, United Kingdom, Cadscan integrates imaging, 3D printing, and 3D visualization technologies to create innovative products. Its offerings include 3D printed insoles, solutions for wound management, and robotic inspection systems. The company also develops a range of medical devices, such as custom orthotics, and employs advanced 3D scanning techniques for various applications. Cadscan Limited's focus on combining cutting-edge technology with practical healthcare solutions positions it as a key player in its industry.

Astrimmune is high throughput fluid-flow cell-Imaging for cancer monitoring.

Gold Standard Phantoms specializes in the development, marketing, and sale of calibration services and devices for quantitative medical imaging, particularly in the realm of MRI technology. The company manufactures cylindrical phantoms that streamline the preparation process by eliminating the need for multiple sample vials, facilitating more efficient calibration. Its offerings include a cloud-based data analysis platform that ensures traceability to standardized values, allowing clinicians, medical physicists, and radiographers to obtain consistent quantitative measurements of diseases across different patients, scanners, and clinical environments. By enhancing the precision of MRI imaging, Gold Standard Phantoms aims to improve diagnostic accuracy and potentially reduce healthcare costs.

GSPK Design is a manufacturer of electronic products specializing in medical device design, industrial instrumentation, and automotive applications. The company offers a wireless patient and control unit that enables small muscle movements to operate assistive technology equipment. In addition to its product development, GSPK Design provides consultation services, electronic design, prototyping, testing, and low-volume manufacturing. This comprehensive approach helps clients address their design and production challenges effectively.

Inspiration Healthcare is a global supplier of medical technology specializing in critical care, operating theatre, and home healthcare applications. The company is dedicated to providing innovative and high-quality products that enhance patient outcomes and improve the efficiency of healthcare organizations. Its portfolio includes critical care solutions such as non-invasive respiratory management, thermoregulation, diagnostics, and patient warming devices tailored for patients ranging from newborns to adults in intensive care and operating rooms. Additionally, Inspiration Healthcare distributes products that support specialized surgical procedures and infusion therapies. The majority of its revenue is generated in the United Kingdom, primarily from its critical care market division.

Owlstone Medical develops and commercializes breathalyzers for clinical diagnostics and precision medicine. Its products detect volatile organic compounds in breath samples to diagnose diseases like lung cancer, asthma, and tuberculosis. The company has strategic collaborations with pharmaceutical companies and is based in Cambridge, UK.

Med ePad, a Liverpool Science Park (UK)-based startup that has developed an interactive touch screen mobile internet device for healthcare service providers.

Lightpoint Medical, Ltd. is a medical device company based in Rickmansworth, United Kingdom, founded in 2012. The company specializes in developing innovative imaging technologies for cancer surgery, specifically through its Cerenkov Luminescence Imaging (CLI) technology. This breakthrough intraoperative imaging method enables real-time cancer detection during surgical procedures, which can significantly reduce the chances of cancer recurrence and the need for subsequent operations. Lightpoint Medical's tools are designed to enhance the effectiveness of robotic cancer surgeries, providing healthcare professionals with critical insights that improve surgical decision-making and patient outcomes while also aiming to lower healthcare costs.

Founded by a consultant ENT surgeon and designer entrepreneur, Cupris Ltd develops smartphone-connected medical devices for remote healthcare. Its flagship product is TYM, a smart otoscope that captures images and videos of the ear, enabling secure sharing via encrypted email. The company ensures data compliance with NHS standards.

AzureIndigo is developing a non-intrusive device to help children aged 4-16 years old with nocturnal enuresis by studying and gently modifying their sleep habits. The overall aim of the project is to develop sensor technology and algorithms to actively intervene before the patient wets the bed.

Taragenyx Ltd. is an orthopedic biotechnology company based in Glasgow, United Kingdom, that specializes in developing innovative self-healing implant technologies to assist the body in its natural repair processes. Founded in 2010 and originally known as RRG Coatings Ltd., Taragenyx focuses on applications in spine, trauma, extremities, and biologics. The company is engaged in creating therapeutic implants featuring bio-passive, bio-active, and bio-regenerative coatings that incorporate active pharmaceuticals and biologics directly onto the implant surfaces. This technology enables localized release of compounds post-operatively, aiming to accelerate bone growth, enhance healing, and diminish the risks of infection and pain. Taragenyx’s products are designed to address and mitigate limb-threatening surgical complications, ultimately improving patient outcomes in orthopedic and dental procedures.

Developer of AI-driven respiratory diagnostic technologies. Its novel sensor technology (N-Tidal) rapidly converts lung function data into respiratory biomarkers for near-real-time analysis. TidalSense has created an affordable, automated COPD diagnostic test that interprets results in under five minutes.

Sensixa Ltd is a London-based company, established in 2006 as a spin-off from the Hamlyn Centre at Imperial College London. The company specializes in the manufacture of advanced wireless sensing devices designed for accurate physical activity monitoring. Sensixa focuses on developing wearable and implantable technologies aimed at healthcare, wellbeing, sports, and gaming applications. Its innovative solutions provide a personalized monitoring platform that is intelligent, context-aware, and minimally intrusive, allowing for natural behaviors without restrictions. The company's expertise lies in low-power micro-electronics, sensor analytics, and behavior profiling. Among its products is an in-ear health monitoring system that transmits vital health information to connected devices, enabling healthcare professionals to assess various physical metrics, including gait, locomotion, and shock wave transmission.

Docobo Ltd is a UK-based medical device company specializing in eHealth solutions aimed at enhancing community care and improving the quality of life for patients, caregivers, and clinicians. The company has developed a digital health and data management platform that facilitates out-of-hospital care by enabling the collection, analysis, and display of patient monitoring data. This platform manages the secure connection, encryption, and transfer of data between the server and patient interaction devices. It empowers patients to self-manage their health at home while allowing clinical teams to enroll, set up, and oversee their patients through secure web interfaces.